Ascend Wellness Holdings (AAWH) Receivables (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Receivables came in at $26.4 million in Q1 2026, down 28.83% year-on-year from $37.1 million in Q1 2025, and down 13.92% quarter-over-quarter from $30.7 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Receivables (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Receivables history runs 7 years deep, the most recent figure standing at $26.4 million for Q1 2026.
- On a quarterly basis, Receivables fell 28.83% year-over-year to $26.4 million in Q1 2026; TTM through Mar 2026 was $26.4 million, a 28.83% decrease from a year earlier, with the FY2025 full-year figure at $30.7 million, down 24.0% from the prior year.
- Receivables fell to $26.4 million in Q1 2026 per AAWH's latest filing, from $30.7 million in the prior quarter.
- Across five years, Receivables topped out at $40.4 million in Q4 2024 and bottomed at $9.3 million in Q2 2022.
- The 5-year median for Receivables is $28.5 million (2023), against an average of $26.4 million.
- Across the five-year window, Receivables soared 138.85% in 2023 and decreased 28.83% in 2026, its largest moves.
- Year by year, Receivables stood at $14.3 million in 2022, then jumped by 99.58% to $28.5 million in 2023, then jumped by 41.88% to $40.4 million in 2024, then retreated by 24.0% to $30.7 million in 2025, then decreased by 13.92% to $26.4 million in 2026.
- Per Business Quant, the three latest AAWH Receivables figures stand at $26.4 million (Q1 2026), $30.7 million (Q4 2025), and $29.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 2.99 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.46 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 312.00 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.29 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.58 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 768.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.15 Bn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 26.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.42 Mn |
| Dec 31, 2025 | 30.70 Mn |
| Sep 30, 2025 | 29.03 Mn |
| Jun 30, 2025 | 30.82 Mn |
| Mar 31, 2025 | 37.12 Mn |
| Dec 31, 2024 | 40.39 Mn |
| Sep 30, 2024 | 38.95 Mn |
| Jun 30, 2024 | 35.49 Mn |
| Mar 31, 2024 | 36.07 Mn |
| Dec 31, 2023 | 28.47 Mn |
| Sep 30, 2023 | 25.55 Mn |
| Jun 30, 2023 | 22.29 Mn |
| Mar 31, 2023 | 19.64 Mn |
| Dec 31, 2022 | 14.26 Mn |
| Sep 30, 2022 | 13.54 Mn |
| Jun 30, 2022 | 9.33 Mn |
| Mar 31, 2022 | 10.53 Mn |
| Dec 31, 2021 | 7.77 Mn |
| Sep 30, 2021 | 12.95 Mn |
| Jun 30, 2021 | 9.28 Mn |